Milestone Scientific Profit Margin

Milestone Scientific (MLSS) currently reports a profit margin of -58.68% as of June 2026. That compares with -101.8% in the prior-year period — up 42.4% year over year. That is below the Healthcare sector average of 13.89%. Use the charts on this page to explore Milestone Scientific's profit margin history and peer comparisons.

Milestone Scientific's profit margin increased from -101.8% to -58.68% — a 42.4% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Milestone Scientific's profit margin of -58.68% is lower than the Healthcare sector average of 13.89%. That is roughly 522.5% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but Milestone Scientific's current -58.68% should be judged against Healthcare norms (sector average: 13.89%) and against MLSS's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of -58.68%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 13.89%. From there, open related valuation or income-statement pages for Milestone Scientific, and consider following MLSS for alerts when major investors trade the stock.